12613 related articles for article (PubMed ID: 10834191)
1. Contribution of whole body F-18-FDG-PET and lymphoscintigraphy to the assessment of regional and distant metastases in cutaneous malignant melanoma. A pilot study.
Klein M; Freedman N; Lotem M; Marciano R; Moshe S; Gimon Z; Chisin R
Nuklearmedizin; 2000; 39(3):56-61. PubMed ID: 10834191
[TBL] [Abstract][Full Text] [Related]
2. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of fluorodeoxyglucose-positron emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy.
Wagner JD; Schauwecker D; Davidson D; Coleman JJ; Saxman S; Hutchins G; Love C; Hayes JT
J Clin Oncol; 1999 May; 17(5):1508-15. PubMed ID: 10334538
[TBL] [Abstract][Full Text] [Related]
4. Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma.
Crippa F; Leutner M; Belli F; Gallino F; Greco M; Pilotti S; Cascinelli N; Bombardieri E
J Nucl Med; 2000 Sep; 41(9):1491-4. PubMed ID: 10994727
[TBL] [Abstract][Full Text] [Related]
5. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
Clark PB; Soo V; Kraas J; Shen P; Levine EA
Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694
[TBL] [Abstract][Full Text] [Related]
6. Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
Wagner T; Meyer N; Zerdoud S; Julian A; Chevreau C; Payoux P; Courbon F
Br J Dermatol; 2011 Jun; 164(6):1235-40. PubMed ID: 21332457
[TBL] [Abstract][Full Text] [Related]
7. Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma.
Havenga K; Cobben DC; Oyen WJ; Nienhuijs S; Hoekstra HJ; Ruers TJ; Wobbes T
Eur J Surg Oncol; 2003 Oct; 29(8):662-4. PubMed ID: 14511614
[TBL] [Abstract][Full Text] [Related]
8. The value of lymph node ultrasound and whole body
Stahlie EHA; van der Hiel B; Bruining A; van de Wiel B; Schrage YM; Wouters MWJM; van Houdt WJ; van Akkooi ACJ
Eur J Surg Oncol; 2021 May; 47(5):1157-1162. PubMed ID: 33353826
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma.
Bedrosian I; Scheff AM; Mick R; Callans LS; Bucky LP; Spitz FR; Helsabeck C; Elder DE; Alavi A; Fraker DF; Czerniecki BJ
J Nucl Med; 1999 Jul; 40(7):1143-8. PubMed ID: 10405134
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of the intra-operative radioguided localization of the sentinel lymph node (SLN) 24 hours after lymphoscintigraphy in patients with malignant melanoma.
Kropp J; Stein A; Hackert I; Sebastian G; Meurer M; Grüning T; Liepe K; Pinkert J; Franke WG
Nuklearmedizin; 2001 Jun; 40(3):86-90. PubMed ID: 11475078
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma.
Macfarlane DJ; Sondak V; Johnson T; Wahl RL
J Clin Oncol; 1998 May; 16(5):1770-6. PubMed ID: 9586890
[TBL] [Abstract][Full Text] [Related]
12. Lymphoscintigraphy in cutaneous melanoma: a total body atlas of sentinel node mapping.
Intenzo CM; Kim SM; Patel JI; Lin HC; Kairys JC
Radiographics; 2002; 22(3):491-502. PubMed ID: 12006683
[TBL] [Abstract][Full Text] [Related]
13. Redefining cutaneous lymphatic flow: the necessity of preoperative lymphoscintigraphy in the management of malignant melanoma.
Kamath D; Rapaport D; DeConti R; Cruse CW; Wells K; Glass F; Messina J; Fenske N; Brobeil A; Berman C; Puleo C; Reintgen D
J Fla Med Assoc; 1997 Mar; 84(3):182-7. PubMed ID: 9143170
[TBL] [Abstract][Full Text] [Related]
14. Baseline staging in cutaneous malignant melanoma.
Hafner J; Schmid MH; Kempf W; Burg G; Künzi W; Meuli-Simmen C; Neff P; Meyer V; Mihic D; Garzoli E; Jungius KP; Seifert B; Dummer R; Steinert H
Br J Dermatol; 2004 Apr; 150(4):677-86. PubMed ID: 15099363
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic mapping and sentinel node biopsy in patients with malignant melanoma.
Reintgen D; Rapaport D; Tanabe KK; Ross M
J Fla Med Assoc; 1997 Mar; 84(3):188-93. PubMed ID: 9143171
[TBL] [Abstract][Full Text] [Related]
16. How many lymph nodes are enough during sentinel lymphadenectomy for primary melanoma?
Porter GA; Ross MI; Berman RS; Sumner WE; Lee JE; Mansfield PF; Gershenwald JE
Surgery; 2000 Aug; 128(2):306-11. PubMed ID: 10923009
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis of sentinel lymph node in malignant melanoma: preoperative lymphoscintigraphy and intraoperative gamma probe guidance].
Dresel S; Weiss M; Heckmann M; Rossmüller B; Konz B; Tatsch K; Hahn K
Nuklearmedizin; 1998 Aug; 37(5):177-82. PubMed ID: 9728345
[TBL] [Abstract][Full Text] [Related]
18. Detection of metastases in patients with cutaneous melanoma using FDG-PET/CT.
Akcali C; Zincirkeser S; Erbagcý Z; Akcali A; Halac M; Durak G; Sager S; Sahin E
J Int Med Res; 2007; 35(4):547-53. PubMed ID: 17697533
[TBL] [Abstract][Full Text] [Related]
19. [PET scanning for malignant melanoma and positive sentinel node diagnostics].
Horn J; Sjøstrand H; Lock-Andersen J; Loft A
Ugeskr Laeger; 2010 Apr; 172(15):1126-30. PubMed ID: 20427004
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.
Kalff V; Hicks RJ; Ware RE; Greer B; Binns DS; Hogg A
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):506-15. PubMed ID: 11914889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
